SlideShare a Scribd company logo
Drugs Affecting Gastrointestinal 
Secretions 
Chapter 57 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Underlying Causes of GI Disorders 
• Dietary Excess 
• Stress 
• Hiatal Hernia 
• Esophageal Reflux 
• Adverse Drug Effects 
• Peptic Ulcer Disease 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Effect of Drugs on GI Secretions 
• Decrease GI secretory activity 
• Block the action of GI secretions 
• Form protective coverings on the GI lining to prevent 
erosion from GI secretions 
• Replace missing GI enzymes that the GI tract or ancillary 
glands and organs can no longer produce 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Peptic Ulcer Disease 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Definition 
– Erosions in the lining of the stomach and adjacent 
areas of the GI tract 
• Symptoms 
– Gnawing, burning pain, often occurring after meals 
• Cause 
– Bacterial infection by Helicobacter pylori bacteria
Drugs Used in the Treatment of Ulcers 
• Histamine-2 (H2) Antagonists 
– Block the release of hydrochloric acid in response to 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
gastrin 
• Antacids 
– Interact with acids at the chemical level to neutralize 
them 
• Proton Pump Inhibitors 
– Suppress the secretion of hydrochloric acid into the 
lumen of the stomach
Drugs Used in the Treatment of Ulcers 
(cont.) 
• Antipeptic Agents 
– Coat any injured area in the stomach to prevent 
further injury from acid 
• Prostaglandins 
– Inhibit the secretion of gastrin and increase the 
secretion of the mucous lining of the stomach, 
providing a buffer 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sites of Actions of Drugs Affecting 
Gastrointestinal Secretions 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Histamine-2 (H2) Antagonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Selectively block histamine-2 receptor sites 
– This blocking leads to a reduction in gastric acid secretion 
and reduction in overall pepsin production 
• Indications 
– Short-term treatment of active duodenal ulcer or benign 
gastric ulcer 
– Treatment of pathological hypersecretory conditions such 
as Zollinger–Ellison syndrome 
– Prophylaxis of stress-induced ulcers and acute upper GI 
bleeding in critical patients
Histamine-2 (H2) Antagonists (cont.) 
• Indications (cont.) 
– Treatment of erosive gastroesophageal reflux 
– Relief of symptoms of heartburn, acid indigestion, 
and sour stomach (OTC preparations) 
• Pharmacokinetics 
– Readily absorbed after oral administration 
– Metabolized in the liver and excreted in urine 
• Contraindications 
– Known allergy 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Histamine-2 (H2) Antagonists (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Pregnancy or lactation 
– Hepatic or renal dysfunction 
• Adverse Effects 
– GI effects 
– CNS effects 
– Cardiac arrhythmias and hypotension 
• Drug-to-Drug Interactions 
– Warfarin, phenytoin, beta blockers, alcohol, quinidine, lidocaine, 
theophylline, chloroquine, benzodiazepines, nifedipine, 
pentoxifylline, tricyclics, procainamide, and carbamazepine
Question 
Drugs act in several ways on the secretions of the GI tract. 
Which action affects the GI secretions least? 
A. Decreases secretory activity 
B. Blocks secretions 
C. Replaces secretions 
D. Prevents erosions 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
C. Replaces secretions 
Rationale: The effects of drugs on GI secretions: decrease 
GI secretory activity; block the action of GI secretions; 
form protective coverings on the GI lining to prevent 
erosion from GI secretions; replace missing GI enzymes 
that the GI tract or ancillary glands and organs can no 
longer produce 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antacids 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Neutralize stomach acid by direct chemical reaction 
• Indications 
– Symptomatic relief of upset stomach associated with 
hyperacidity, as well as hyperactivity 
• Contraindications 
– Allergy 
• Caution 
– Any condition that can be exacerbated by electrolyte 
imbalance 
– GI obstruction
Antacids (cont.) 
• Adverse Effects 
– Relate to their effects on acid-base levels and 
electrolytes 
– Rebound acidity 
– Alkalosis 
– Hypercalcemia 
– Constipation or diarrhea 
– Hypophosphatemia 
• Drug-to-Drug Interactions 
– Affect the absorption of many other drugs 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Proton Pump Inhibitors 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Act at specific secretory surface receptors to prevent the final 
step of acid production and thereby decrease the level of acid in 
the stomach 
• Indications 
– Short-term treatment of active duodenal ulcers, GERD, erosive 
esophagitis, and benign active gastric disease 
– Long-term treatment of pathological hypersecretory conditions 
• Pharmacokinetics 
– Acid labile, rapidly absorbed in the GI tract 
– Metabolized in the liver and excreted in the urine
Proton Pump Inhibitors (cont.) 
• Contraindications 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
– Allergy 
• Caution 
– Pregnancy or lactation 
• Adverse Effects 
– CNS effects 
• Dizziness, headache, asthenia, vertigo, insomnia, 
apathy
Proton Pump Inhibitors (cont.) 
• Adverse Effects (cont.) 
– GI Effects 
• Diarrhea, abdominal pain, and tongue atrophy 
– Upper respiratory tract symptoms 
• Cough, stuff nose, hoarseness, and epistaxis 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
– Other 
• Rash, alopecia, pruritis, dry skin, back pain, and 
fever
Antipeptic Agent 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Forms an ulcer-adherent complex at duodenal ulcer sites, 
protecting the sites against acid, pepsin, and bile salts 
• Indications 
– Promote ulcer healing 
• Pharmacokinetics 
– Rapidly absorbed, metabolized in the liver, and excreted in 
feces 
• Contraindications 
– Allergy 
– Renal failure
Antipeptic Agent (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Pregnancy or lactation 
• Adverse Effects 
– GI effects – Constipation, diarrhea, nausea, 
indigestion, gastric discomfort, dry mouth 
– Dizziness 
– Sleepiness 
– Vertigo 
– Skin rash 
– Back pain
Antipeptic Agent (cont.) 
• Drug-to-Drug Interactions 
– Aluminum salts 
– Phenytoin, fluoroquinolone, or penicillamine 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prostaglandin 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Inhibits gastric acid secretion and increases bicarbonate 
and mucous production in the stomach 
• Indications 
– Prevention of NSAID-induced gastric ulcers 
– Treatment of duodenal ulcers 
• Pharmacokinetics 
– Rapidly absorbed from GI tract, metabolized in the liver, 
and excreted in the urine 
• Contraindications 
– Pregnancy
Prostaglandin (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Lactation 
• Adverse Effects 
– GI effects – Nausea, diarrhea, abdominal pain, 
flatulence, vomiting, dyspepsia, and constipation 
– GU effects – Miscarriages, excessive bleeding, 
spotting, cramping, hypermenorrhea, dysmenorrhea, 
and other menstrual disorders
Question 
Please answer the following statement as true or false. 
There is a drug-drug interaction between the antipeptides 
and penicillin. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
False 
Rationale: Drug-to-drug interactions include aluminum 
salts, phenytoin, fluoroquinolone, or penicillamine. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Patients Who May Require Digestive 
Enzyme Supplements 
• Saliva Supplements 
– Stroke 
– Salivary gland disorder 
– Extreme surgery of the head and neck 
• Pancreatic Enzyme Supplements 
– Common duct problems 
– Pancreatic disease 
– Cystic fibrosis 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Digestive Enzymes 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Saliva substitute – Contains electrolytes and 
carboxymethylcellulose to act as a thickening agent 
in dry mouth conditions 
– Pancreatic enzymes are replacement enzymes that 
help the digestion and absorption of fats, proteins, 
and carbohydrates 
• Indications 
– Replacement therapy
Digestive Enzymes (cont.) 
• Contraindications 
– Saliva – Allergy 
– Pancreatic enzymes - Allergy 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Saliva – CHF, hypertension, or renal failure 
– Pancreatic enzyme – Pregnancy and lactation
Digestive Enzymes (cont.) 
• Adverse Effects 
– Saliva – Complications from abnormal electrolytes – 
increased levels of magnesium, sodium, or potassium 
– Pancreatic enzyme – GI irritation, nausea, abdominal 
cramps, and diarrhea 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Agents Affecting Gastrointestinal 
Secretions Across the Lifespan 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Histamine-2 (H2) Antagonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Antacids 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Proton Pump Inhibitors 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Digestive Enzymes 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
What H2 antagonist has been associated with 
antiandrongenic effects? 
A. Famotidine 
B. Cimetidine 
C. Nizatidine 
D. Ranitidine 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
B. Cimetidine 
Rationale: Cimetidine was the first drug in this class to be 
developed. It has been associated with antiandrongenic 
effects, including gynecomastia and galactorrhea. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Histamine-2 
(H2) Antagonists 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Antacids 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Proton Pump 
Inhibitors 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Antipeptic 
Agent 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Prostaglandin 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Digestive 
Enzymes 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

Ppt chapter 32-1
Ppt chapter 32-1Ppt chapter 32-1
Ppt chapter 32-1
stanbridge
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1
stanbridge
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
stanbridge
 
Ppt chapter 44
Ppt chapter 44Ppt chapter 44
Ppt chapter 44
stanbridge
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34
stanbridge
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
stanbridge
 
Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04
stanbridge
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42
stanbridge
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
stanbridge
 
Ppt chapter 14
Ppt chapter 14Ppt chapter 14
Ppt chapter 14
stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
stanbridge
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
stanbridge
 
Paediatric pharmacology
Paediatric pharmacologyPaediatric pharmacology
Paediatric pharmacology
Sathish Babu
 
Pharmacology of diabetes mellitus
Pharmacology of diabetes mellitusPharmacology of diabetes mellitus
Pharmacology of diabetes mellitus
Dalia Zaafar
 
Pharmacology Git Drugs
Pharmacology   Git DrugsPharmacology   Git Drugs
Pharmacology Git Drugs
pinoy nurze
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
stanbridge
 
Gastrointestinal medications
Gastrointestinal medicationsGastrointestinal medications
Gastrointestinal medications
Carmina Gurrea
 
Pharmacology - Antivirals
Pharmacology - AntiviralsPharmacology - Antivirals
Pharmacology - Antivirals
Areej Abu Hanieh
 
Drugs acting on the immune system
Drugs acting on the immune systemDrugs acting on the immune system
Drugs acting on the immune system
ShaikhSaniya2
 

What's hot (20)

Ppt chapter 32-1
Ppt chapter 32-1Ppt chapter 32-1
Ppt chapter 32-1
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Ppt chapter 44
Ppt chapter 44Ppt chapter 44
Ppt chapter 44
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 14
Ppt chapter 14Ppt chapter 14
Ppt chapter 14
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Paediatric pharmacology
Paediatric pharmacologyPaediatric pharmacology
Paediatric pharmacology
 
Pharmacology of diabetes mellitus
Pharmacology of diabetes mellitusPharmacology of diabetes mellitus
Pharmacology of diabetes mellitus
 
Pharmacology Git Drugs
Pharmacology   Git DrugsPharmacology   Git Drugs
Pharmacology Git Drugs
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Gastrointestinal medications
Gastrointestinal medicationsGastrointestinal medications
Gastrointestinal medications
 
Pharmacology - Antivirals
Pharmacology - AntiviralsPharmacology - Antivirals
Pharmacology - Antivirals
 
Drugs acting on the immune system
Drugs acting on the immune systemDrugs acting on the immune system
Drugs acting on the immune system
 

Viewers also liked

Noli me tangere reporting
Noli me tangere reportingNoli me tangere reporting
Noli me tangere reportingSInXcro
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
stanbridge
 
Noli Me Tangere
Noli Me TangereNoli Me Tangere
Noli Me Tangere
menchu lacsamana
 
Noli me tangere kabanata 57 58
Noli me tangere kabanata 57 58Noli me tangere kabanata 57 58
Noli me tangere kabanata 57 58mojarie madrilejo
 
Fil noli-me-tangere kab1-64
Fil noli-me-tangere kab1-64Fil noli-me-tangere kab1-64
Fil noli-me-tangere kab1-64
sdawqe123
 
Chapter 57
Chapter 57Chapter 57
Chapter 57
mcfalltj
 
Med chem lecture on Antihistaminicdrugs
Med chem lecture on AntihistaminicdrugsMed chem lecture on Antihistaminicdrugs
Med chem lecture on Antihistaminicdrugs
sagar joshi
 
CHEMISTRY OF ANTI SECRETORY DRUGS
CHEMISTRY OF ANTI SECRETORY DRUGSCHEMISTRY OF ANTI SECRETORY DRUGS
CHEMISTRY OF ANTI SECRETORY DRUGS
Syed Nayyer Alvi
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
stanbridge
 
Noli me tangere kabanata 62 63-64
Noli me tangere kabanata 62 63-64Noli me tangere kabanata 62 63-64
Noli me tangere kabanata 62 63-64mojarie madrilejo
 
Important questions with biochemistry
Important questions with biochemistryImportant questions with biochemistry
Important questions with biochemistry
sathish srn
 
H2 antagonist and ppi
H2 antagonist and ppiH2 antagonist and ppi
H2 antagonist and ppi
naseefa
 
Histamine & bradykinin
Histamine & bradykininHistamine & bradykinin
Histamine & bradykinin
ankit
 
Filipino noli-me-tangere kab1-64
Filipino  noli-me-tangere kab1-64Filipino  noli-me-tangere kab1-64
Filipino noli-me-tangere kab1-64
Eemlliuq Agalalan
 
Noli me tangere kabanata 59 60
Noli me tangere kabanata 59 60Noli me tangere kabanata 59 60
Noli me tangere kabanata 59 60mojarie madrilejo
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
pharmastuffblogspotcom
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
Raju Sanghvi
 
Antihistamine
Antihistamine Antihistamine
Antihistamine
Ahmad AlJifri
 
Noli Me Tangere
Noli Me TangereNoli Me Tangere
Noli Me Tangere
guest9c5609165
 

Viewers also liked (20)

Noli me tangere reporting
Noli me tangere reportingNoli me tangere reporting
Noli me tangere reporting
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
 
Noli Me Tangere
Noli Me TangereNoli Me Tangere
Noli Me Tangere
 
Noli me tangere kabanata 57 58
Noli me tangere kabanata 57 58Noli me tangere kabanata 57 58
Noli me tangere kabanata 57 58
 
Buod ng Noli 49- 64
Buod ng Noli 49- 64Buod ng Noli 49- 64
Buod ng Noli 49- 64
 
Fil noli-me-tangere kab1-64
Fil noli-me-tangere kab1-64Fil noli-me-tangere kab1-64
Fil noli-me-tangere kab1-64
 
Chapter 57
Chapter 57Chapter 57
Chapter 57
 
Med chem lecture on Antihistaminicdrugs
Med chem lecture on AntihistaminicdrugsMed chem lecture on Antihistaminicdrugs
Med chem lecture on Antihistaminicdrugs
 
CHEMISTRY OF ANTI SECRETORY DRUGS
CHEMISTRY OF ANTI SECRETORY DRUGSCHEMISTRY OF ANTI SECRETORY DRUGS
CHEMISTRY OF ANTI SECRETORY DRUGS
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 
Noli me tangere kabanata 62 63-64
Noli me tangere kabanata 62 63-64Noli me tangere kabanata 62 63-64
Noli me tangere kabanata 62 63-64
 
Important questions with biochemistry
Important questions with biochemistryImportant questions with biochemistry
Important questions with biochemistry
 
H2 antagonist and ppi
H2 antagonist and ppiH2 antagonist and ppi
H2 antagonist and ppi
 
Histamine & bradykinin
Histamine & bradykininHistamine & bradykinin
Histamine & bradykinin
 
Filipino noli-me-tangere kab1-64
Filipino  noli-me-tangere kab1-64Filipino  noli-me-tangere kab1-64
Filipino noli-me-tangere kab1-64
 
Noli me tangere kabanata 59 60
Noli me tangere kabanata 59 60Noli me tangere kabanata 59 60
Noli me tangere kabanata 59 60
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
 
Antihistamine
Antihistamine Antihistamine
Antihistamine
 
Noli Me Tangere
Noli Me TangereNoli Me Tangere
Noli Me Tangere
 

Similar to Ppt chapter 57

Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
stanbridge
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
stanbridge
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1
stanbridge
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47
stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
stanbridge
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1
stanbridge
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
stanbridge
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51
stanbridge
 
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Vinitkumar MJ
 
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLEPEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
Olusegun Thomas
 
Antidiarrheal agents
Antidiarrheal agentsAntidiarrheal agents
Antidiarrheal agents
Domina Petric
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1
stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
stanbridge
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
BikashAdhikari26
 

Similar to Ppt chapter 57 (20)

Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1
 
Ppt chapter 56
Ppt chapter 56Ppt chapter 56
Ppt chapter 56
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51
 
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
Drugs used in git system (GIT - Laxatives /purgatives , drugs used to treat p...
 
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLEPEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
PEPTIC ULCER, ITS MANAGEMENT AND OMEPRAZOLE
 
Antidiarrheal agents
Antidiarrheal agentsAntidiarrheal agents
Antidiarrheal agents
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
stanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
stanbridge
 
Sample poster
Sample posterSample poster
Sample poster
stanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
stanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
stanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
stanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
stanbridge
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
stanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 57

  • 1. Drugs Affecting Gastrointestinal Secretions Chapter 57 Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Underlying Causes of GI Disorders • Dietary Excess • Stress • Hiatal Hernia • Esophageal Reflux • Adverse Drug Effects • Peptic Ulcer Disease Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 3. Effect of Drugs on GI Secretions • Decrease GI secretory activity • Block the action of GI secretions • Form protective coverings on the GI lining to prevent erosion from GI secretions • Replace missing GI enzymes that the GI tract or ancillary glands and organs can no longer produce Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 4. Peptic Ulcer Disease Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Definition – Erosions in the lining of the stomach and adjacent areas of the GI tract • Symptoms – Gnawing, burning pain, often occurring after meals • Cause – Bacterial infection by Helicobacter pylori bacteria
  • 5. Drugs Used in the Treatment of Ulcers • Histamine-2 (H2) Antagonists – Block the release of hydrochloric acid in response to Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins gastrin • Antacids – Interact with acids at the chemical level to neutralize them • Proton Pump Inhibitors – Suppress the secretion of hydrochloric acid into the lumen of the stomach
  • 6. Drugs Used in the Treatment of Ulcers (cont.) • Antipeptic Agents – Coat any injured area in the stomach to prevent further injury from acid • Prostaglandins – Inhibit the secretion of gastrin and increase the secretion of the mucous lining of the stomach, providing a buffer Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 7. Sites of Actions of Drugs Affecting Gastrointestinal Secretions Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 8. Histamine-2 (H2) Antagonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Selectively block histamine-2 receptor sites – This blocking leads to a reduction in gastric acid secretion and reduction in overall pepsin production • Indications – Short-term treatment of active duodenal ulcer or benign gastric ulcer – Treatment of pathological hypersecretory conditions such as Zollinger–Ellison syndrome – Prophylaxis of stress-induced ulcers and acute upper GI bleeding in critical patients
  • 9. Histamine-2 (H2) Antagonists (cont.) • Indications (cont.) – Treatment of erosive gastroesophageal reflux – Relief of symptoms of heartburn, acid indigestion, and sour stomach (OTC preparations) • Pharmacokinetics – Readily absorbed after oral administration – Metabolized in the liver and excreted in urine • Contraindications – Known allergy Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 10. Histamine-2 (H2) Antagonists (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Pregnancy or lactation – Hepatic or renal dysfunction • Adverse Effects – GI effects – CNS effects – Cardiac arrhythmias and hypotension • Drug-to-Drug Interactions – Warfarin, phenytoin, beta blockers, alcohol, quinidine, lidocaine, theophylline, chloroquine, benzodiazepines, nifedipine, pentoxifylline, tricyclics, procainamide, and carbamazepine
  • 11. Question Drugs act in several ways on the secretions of the GI tract. Which action affects the GI secretions least? A. Decreases secretory activity B. Blocks secretions C. Replaces secretions D. Prevents erosions Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Answer C. Replaces secretions Rationale: The effects of drugs on GI secretions: decrease GI secretory activity; block the action of GI secretions; form protective coverings on the GI lining to prevent erosion from GI secretions; replace missing GI enzymes that the GI tract or ancillary glands and organs can no longer produce Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Antacids Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Neutralize stomach acid by direct chemical reaction • Indications – Symptomatic relief of upset stomach associated with hyperacidity, as well as hyperactivity • Contraindications – Allergy • Caution – Any condition that can be exacerbated by electrolyte imbalance – GI obstruction
  • 14. Antacids (cont.) • Adverse Effects – Relate to their effects on acid-base levels and electrolytes – Rebound acidity – Alkalosis – Hypercalcemia – Constipation or diarrhea – Hypophosphatemia • Drug-to-Drug Interactions – Affect the absorption of many other drugs Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 15. Proton Pump Inhibitors Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Act at specific secretory surface receptors to prevent the final step of acid production and thereby decrease the level of acid in the stomach • Indications – Short-term treatment of active duodenal ulcers, GERD, erosive esophagitis, and benign active gastric disease – Long-term treatment of pathological hypersecretory conditions • Pharmacokinetics – Acid labile, rapidly absorbed in the GI tract – Metabolized in the liver and excreted in the urine
  • 16. Proton Pump Inhibitors (cont.) • Contraindications Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins – Allergy • Caution – Pregnancy or lactation • Adverse Effects – CNS effects • Dizziness, headache, asthenia, vertigo, insomnia, apathy
  • 17. Proton Pump Inhibitors (cont.) • Adverse Effects (cont.) – GI Effects • Diarrhea, abdominal pain, and tongue atrophy – Upper respiratory tract symptoms • Cough, stuff nose, hoarseness, and epistaxis Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins – Other • Rash, alopecia, pruritis, dry skin, back pain, and fever
  • 18. Antipeptic Agent Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Forms an ulcer-adherent complex at duodenal ulcer sites, protecting the sites against acid, pepsin, and bile salts • Indications – Promote ulcer healing • Pharmacokinetics – Rapidly absorbed, metabolized in the liver, and excreted in feces • Contraindications – Allergy – Renal failure
  • 19. Antipeptic Agent (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Pregnancy or lactation • Adverse Effects – GI effects – Constipation, diarrhea, nausea, indigestion, gastric discomfort, dry mouth – Dizziness – Sleepiness – Vertigo – Skin rash – Back pain
  • 20. Antipeptic Agent (cont.) • Drug-to-Drug Interactions – Aluminum salts – Phenytoin, fluoroquinolone, or penicillamine Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 21. Prostaglandin Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Inhibits gastric acid secretion and increases bicarbonate and mucous production in the stomach • Indications – Prevention of NSAID-induced gastric ulcers – Treatment of duodenal ulcers • Pharmacokinetics – Rapidly absorbed from GI tract, metabolized in the liver, and excreted in the urine • Contraindications – Pregnancy
  • 22. Prostaglandin (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Lactation • Adverse Effects – GI effects – Nausea, diarrhea, abdominal pain, flatulence, vomiting, dyspepsia, and constipation – GU effects – Miscarriages, excessive bleeding, spotting, cramping, hypermenorrhea, dysmenorrhea, and other menstrual disorders
  • 23. Question Please answer the following statement as true or false. There is a drug-drug interaction between the antipeptides and penicillin. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Answer False Rationale: Drug-to-drug interactions include aluminum salts, phenytoin, fluoroquinolone, or penicillamine. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Patients Who May Require Digestive Enzyme Supplements • Saliva Supplements – Stroke – Salivary gland disorder – Extreme surgery of the head and neck • Pancreatic Enzyme Supplements – Common duct problems – Pancreatic disease – Cystic fibrosis Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Digestive Enzymes Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Saliva substitute – Contains electrolytes and carboxymethylcellulose to act as a thickening agent in dry mouth conditions – Pancreatic enzymes are replacement enzymes that help the digestion and absorption of fats, proteins, and carbohydrates • Indications – Replacement therapy
  • 27. Digestive Enzymes (cont.) • Contraindications – Saliva – Allergy – Pancreatic enzymes - Allergy Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Saliva – CHF, hypertension, or renal failure – Pancreatic enzyme – Pregnancy and lactation
  • 28. Digestive Enzymes (cont.) • Adverse Effects – Saliva – Complications from abnormal electrolytes – increased levels of magnesium, sodium, or potassium – Pancreatic enzyme – GI irritation, nausea, abdominal cramps, and diarrhea Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Use of Agents Affecting Gastrointestinal Secretions Across the Lifespan Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Prototype Histamine-2 (H2) Antagonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Prototype Antacids Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 32. Prototype Proton Pump Inhibitors Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 33. Prototype Digestive Enzymes Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 34. Question What H2 antagonist has been associated with antiandrongenic effects? A. Famotidine B. Cimetidine C. Nizatidine D. Ranitidine Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 35. Answer B. Cimetidine Rationale: Cimetidine was the first drug in this class to be developed. It has been associated with antiandrongenic effects, including gynecomastia and galactorrhea. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 36. Nursing Considerations for Histamine-2 (H2) Antagonists • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 37. Nursing Considerations for Antacids • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 38. Nursing Considerations for Proton Pump Inhibitors • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 39. Nursing Considerations for Antipeptic Agent • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 40. Nursing Considerations for Prostaglandin • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 41. Nursing Considerations for Digestive Enzymes • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins